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The ability of T-helper cells (TH) 1 to ,~ug.~.~ the activity of cytotoxic T  lympho- 
cytes (CTL) has been extensively characterized (1). In particular, Lyt-1  ÷ Tn or their 
products (presumably interleukin 2 [IL-2])  have been shown to increase the amount 
of cytolytic activity generated in in vitro culture systems (2-8). However, it has been 
difficult to demonstrate that helper activity is requisite for the sensitization of CTL 
precursors (CTL-P). Thus, while there is an absolute requirement for the addition of 
helper activity in order to sensitize anti-H-2 and anti-trinitrophenyl (TNP)  thymic 
CTL-P (9, 10), precursors obtained from peripheral lymphoid organs can be sensitized 
to the same epitopes without the addition of exogenous helper activity (9,  11). This 
latter observation could reflect either the presence of endogenous TH in these organs, 
or the ability of CTL-P to be activated in a helper-cell independent manner. Evidence 
in favor of the first possibility has been obtained by showing that helper activity is 
required for the generation of CTL when antigen-presenting cells have been pretreated 
with physical agents; e.g., heat, ultraviolet light, sonication, etc.  (12-14).  However, 
presentation of epitopes on cells treated in the above manner may not accurately 
reflect the ability of CTL-P to become activated. Therefore, whereas CTL activity 
can be augmented in peripheral lymphoid organs by TH, definitive evidence demon- 
strating a requirement for TH is lacking. 
Even less is known about the role of TH in allowing for the activation and generation 
of CTL from CTL-P in vivo. Indirect evidence indicating TH are needed in vivo was 
provided by Zinkernagel et al.  (15) and von Boehmer and Haas (16),  who showed, 
using bone marrow repopulated radiation chimeras, that there is a  requirement for 
I region sharing between CTL and radiation-resistant thymus cells to generate anti- 
viral and anti-H-Y effector cell activity. Presumably in these instances TH are ! region 
restricted. More direct evidence has been provided by Altman et al. (17) and Butler 
and Battisto (18), who showed that increased CTL activity is generated against tumor 
or TNP antigenic determinants if helper antigens are present during sensitization. On 
the other  hand,  Bevan  (19) showed that  in  vitro-generated CTL directed  agaifist 
minor-H-antigens required prior in vivo priming but found no evidence to indicate 
that helper cells were involved. 
The data in this report use the CTL response against the Qa-1 b alloantigen. The 
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response to this determinant  requires prior in vivo priming in order to generate CTL 
activity in vitro (20-23). The effector cells generated are H-2 unrestricted and specific 
for Qa-1, a cell surface glycoprotein that is structurally similar to H-2 class I antigens 
(24). 
The results of our investigation indicate that in vitro CTL-P cannot be generated 
against  the Qa-1  antigen  unless  animals  are first  primed  in vivo with  two different 
types of antigenic determinants. One of the determinants is Qa-1 and is recognized by 
CTL-P.  However,  in  the  absence  of an  additional  or second  (helper)  determinant 
successful in vivo priming does not occur. Recognition of this helper determinant  is 
under  H-2-1inked  immune  response  (Ir)  gene  control.  Although  we  were  able  to 
demonstrate an obligatory role for helper determinants  in vivo, no such requirement 
could be detected for the generation of anti-Qa- 1 CTL from primed CTL-P in vitro. 
Materials  and Methods 
Animals.  A/J mice were obtained from The Jackson Laboratories, Bar Harbor, ME. B6.TIa  a 
mice were kindly provided by Dr. L. Flaherty, New York State Department of Health, Albany, 
NY. All other mice were bred in our colonies at the University of Texas Health Science Center 
at Dallas. 
Immunization Procedures.  Recipient mice were injected with 40-70 X  106 spleen cells intra- 
peritoneally, unless otherwise stated, and sacrificed 3 wk to 4 mo later. 
Cytotoxicity Assay.  The assay has been previously described (23). Briefly, 5 X  106 responder 
spleen cells and  1 X  106 irradiated  (3,000 rad) stimulator cells were cultured in 35-mm petri 
dishes  in RPMI 1640 with supplements including 5% fetal calf serum (FCS). Unless otherwise 
stated, the effector cells were harvested from petri dishes after 5 d in culture, adjusted to the 
appropriate  concentrations in 0.1  ml  of medium,  and  added  to individual  wells  in  round- 
bottomed microtiter plates with 0.1 mi of  ~XCr-labeled Isolymph-(Gallard-Schlesinger Chemical 
Mfg. Corp., Carle Place, NY) purified concanavalin A (Con A) lymphoblast target cells. These 
plates were then incubated at  37°C and harvested 4 h  later.  The data are expressed as net 
isotope release.  This represents the percent 51Cr release  from target cells in the presence of in 
vivo-primed spleen cells  cultured  with stimulator cells  minus the percent nXCr release  from 
target cells  in the presence of in vivo primed spleen  cells cultured  without stimulator cells. 
Standard errors of the mean from triplicate samples did not exceed 5%. 
Tissue Typing.  (A/J  X  B6.Tlaa)F1  X  B6.Tla  a backcross mice were typed for H-2K  k in a 
microcytotoxicity assay as previously described  (25).  An anti-H-2K  k IgG~ hybridoma (Salk 
line  11-4.1) was used  together with  low-toxicity rabbit  complement  (Pel-Freez  Biologicals, 
Rogers, AR) to type for the H-2  ~ haplotype. In each experiment,  (A/J X B6.Tlaa)F1  and B6 
mice were typed as positive and negative controls, respectively. 
Results 
B6.Tla a Mice Do not Respond to the Qa-I b Alloantigen.  There are currently available 
two  Qa-1/Tla  congenic  pairs  of mice:  (a)  A.TIa  b,  and  (b)  B6.TIa  a,  C57BL/6  (B6). 
A.Tla  b is an A-background mouse that has derived its Qa-1/Tla chromosomal segment 
from B6. Similarly, B6.Tla  a is a  B6-background mouse that has derived its Qa-1/Tla 
chromosomal segment from A  (Fig.  1). Since H-2 unrestricted CTL can be generated 
against the Qa-1 b alloantigen in a  secondary cell-mediated lympholysis (CML) assay 
(20-23),  both congenic pairs should be able to generate anti-Qa-I b CTL.  However, 
we have previously reported  (23)  that anti-Qa-1 b CTL can be generated in only one 
of  these  two  congenic  pairs.  Thus,  A/J  (Qa-1 ~)  mice  can  generate  CTL  when 
immunized in vivo and restimulated  in vitro with Qa-1 b congenic A.Tla  b spleen cells. 
In contrast, B6.Tla  a (Qa-1 a) mice cannot generate CTL when immunized with Qa-1 b 
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F:c.  1.  Schematic representation of the H-2-Tla  interval on the  17th chromosome of A  and B6 
Qa/Tla congenic strains. ~,  B6; m, A/J;  D,  origin of chromosome uncertain, either  from B6 or 
A/J. 
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FIG.  2.  Kinetics of the anti-Qa-1  response. A/J  mice were  primed in  vivo with  Qa-1  congenic 
spleen  cells  (A.Tla  b)  and  restimulated in  vitro  for  a  varying number of days  (4-7)  with  either 
irradiated  Qa-1  congenic  (A.Tla  b)  spleen cells  (0--.-0),  or  irradiated  H-2  allogeneic  (B6)  spleen 
cells (×----×). Effector cells were tested for their cytotoxic activity against ~:Cr-labeled B6 Con A 
lymphoblast target cells. B6.TIa" mice were primed twice in vivo with Qa-1  congenic (B6)  spleen 
cells and restimulated in vitro for a  varying number of days with either irradiated Qa-1  congenic 
(B6)  spleen cells (O  O), or irradiated  H-2 allogeneic (A/J) spleen cells (×  X). Effector cells 
were tested against A.TIa  b target cells. Effector/target  (E/T)  ratio is 100:1. 
It  is  possible  that  the  apparent  inability of B6.Tla  a mice to  generate  anti-Qa-1 b 
CTL is  due  to a  difference in  the  kinetics  of the  response in  B6.Tla  a mice relative 
to A strain mice. Accordingly, both A/J and B6.Tla" mice were primed in vivo with 
Qa-1  congenic spleen cells  and  restimulated  in  vitro  for a  varying number of days 
with either irradiated Qa-1 congenic spleen cells  or irradiated  H-2 allogeneic spleen 
cells as a control (Fig.  2). In all experiments where anti-Qa-1 CTL activity was tested, 
A/J anti-A.Tla  b effector cells were tested against B6 targets, whereas B6.Tla" anti-B6 
effectors were  tested  against  A.Yla  b targets.  This  was  done to  insure  that  we were 
measuring H-2-unrestricted anti-Qa-1  b  CTL activity. A/J mice generated both anti- 
O a-1 b and anti-H-2 cytotoxic activity with peak lytic values noted at 6 d. In contrast, 
although B6.Tla  a strain mice generated anti-H-2 CTL, at no time did they show any J.  KEENE  AND J.  FORMAN  771 
anti-Qa-1 b cytotoxic activity. Therefore, B6.TIa  a mice are nonresponders throughout 
the time course of the in vitro assay. 
Although intraperitoneal inoculation did not sensitize B6.Tla  a mice to Qa-1 b on B6 
splenocytes,  other  routes  of  immunization  might  be  more  effective.  Accordingly, 
various routes of in  vivo immunization  including  intraperitoneal,  intravenous,  sub- 
cutaneous, and via the footpad were tested. The data presented in Fig. 3 demonstrate 
that the ability of A/J or the inability of B6.TIa  a mice to respond was not altered by 
any of these protocols.  Further,  whereas a  single inoculation  of 30 ×  106 B6 spleen 
cells  in  vivo  is  ineffective  in  sensitizing  B6.TIa  a  mice,  multiple  injections  or  an 
increased  number of cells  in  the  inoculum  might  allow for the  generation  of anti- 
Qa-1  b CTL. However, neither two inoculations of priming cells (Fig. 1) nor increasing 
the number of cells in the inoculum to  115  ×  106 (data not shown)  resulted in anti- 
Qa- 1 CTL. 
The Inability of B6. Tla  a Mice to Respond to Qa-1 b Is not due to an Absence of CTL-P.  The 
inability  of B6.TIa  a  mice  to  generate  anti-Qa-1 b CTL  could  be  due  to  either  an 
absence of anti-Qa-1 b CTL-P or an  inability  to  sensitize CTL-P in  these  animals. 
Evidence in  favor of the latter possibility was obtained by in vivo priming B6.Tla  ~ 
mice with spleen cells from animals other than B6. Thus, B6.Tla  ~ mice do generate 
anti-Qa-1 b CTL when immunized in vivo with A.BY rather than B6 spleen cells (Fig. 
4). A.BY mice have the same H-2 and Qa-1 alleles as B6 (H-2  b, Qa-1 b) but differ from 
B6 (and B6.TIa  ~) at multiple background loci. 
In addition  to A.BY cells,  female B6.TIa" nonresponder  mice also generate anti- 
Qa-1 b CTL when immunized in vivo with B6 male spleen cells (Fig. 4). Apparently, 
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Fzc.  3.  The route of immunization does not alter the ability to respond to Qa- 1. A/J (- - -) and 
B6.TIa  m (  )  mice  were  primed  in  vivo  with  Qa-1  congenic spleen  cells  (A.Tla  b  and  B6, 
respectively) by various routes of immunization (intraperitoneal (*), intravenous (O), subcutaneous 
(x), and via the footpad (+), and restimulated in vitro with irradiated Qa-1 congenic spleen cells. 
A/J and B6.Tlam effector cells were tested for their cytotoxic activity against 5XCr-labeled  Con A 
lymphoblast Qa-I b target cells (B6 and A.TIa  b, respectively) at E/T ratios of 10:1, 50: I, and  100: L. 772  HELPER DETERMINANTS FOR CYTOTOXIC T  LYMPHOCYTES 
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Fro. 4.  B6,TIa  a mice have CTL-P that recognize Qa-1  b. B6.TIa" male mice were primed in vivo 
with sex-matched B6 spleen cells (O) or A.BY spleen cells (+) and restimulated in vitro with sex- 
matched Qa-1 congenic B6 splenocytes. B6.TIa" female mice were primed in vivo with sex-matched 
B6 spleen cells (*) or B6 male cells (X) and restimulated in vitro with B6 male splenoeytes. Effector 
cells were tested for cytotoxic activity against SXCr-labeled Con A lymphoblast A.TIa  b target cells 
from female mice at E/T ratios of 10:1, 50:1, and 100:1. 
the addition of the H-Y antigenic disparity on the immunizing cells converts female 
B6.TIa  a nonresponder mice into responders.  It is important  to note that  the effector 
cells generated are specific for the Qa-1 b alloantigen and not H-Y, because the target 
cells  used  in  the  assay  are  obtained  from  female  mice.  Therefore,  the  above  data 
demonstrate that  the  inability  of B6.Tla"  mice to respond  to the Qa-1 b alloantigen 
when  primed  with  B6  spleen  cells  is  not  due  to  a  lack of CTL-P,  but  rather  the 
inability of B6 cells to sensitize CTL-P in vivo. 
The Requirement  for H-Y and Qa-1 To Be Presented on the Same Immunizing  Cell.  The 
ability of B6.TIa  * mice to respond to Qa-1  if primed with non-Qa-1 congenic spleen 
cells could be due to a  nonspecific adjuvant effect induced by the extra antigen.  On 
the other hand,  in analogy with T-B collaboration, there  may be a  requirement  for 
linked recognition suggesting specific recognition of the extra determinant.  This issue 
was  addressed  by determining  if both  antigens,  Qa-1  and  H-Y,  need  to be on the 
same cell used for in vivo priming. 
B6.TIa  ~ female mice were immunized intraperitoneally with a  mixture of 30 ×  106 
B6.Tla  ~ male spleen cells and 30 ×  106 B6 female spleen cells. Accordingly, each cell 
presents either the H-Y or the Qa-1 alloantigen,  respectively. The data presented  in 
Table I  demonstrate a  requirement  for both antigenic determinants  to be presented 
on  the  same  cell  for  successful  immunization.  Accordingly,  cytotoxic  activity  is 
generated when B6.Tla  ~ female mice are primed in vivo with B6 male spleen cells but 
not B6 female cells, as expected  (lines  1 and 2).  However, no cytotoxic activity was 
generated when H-Y and Qa-1 were presented on separate cells (lines 3 and 4), even 
when both antigens were presented on the same cell  (line 3)  during in vitro restimu- j.  KEENE AND J.  FORMAN  773 
TABLE I 
H-Y and Qa- I Must Be Present on the Same Cell for Successful Priming Intraperitoneally 
Line 
Stimulator cells  Net SXCr release  Responder  Target 
cells  cells  In Vivo  In Vitro  100  50  10 
1  B6.TIa" 9  B6 9  B6 9  A.TIa  b 9  1.2  0.9  0.5 
2  B6 d  B6 d  53.2  49.9  34.4 
3  B6.TIa" d + B6 9  B6 d  0.9  0.9  1.5 
4  B6.TIa" d + B6 9  B6.TIa  ~ d +  B6 ~  5.3  7.4  4.8 
B6.TIa" female mice were immunized intraperitoneally with 30 ×  100 B6 female sgleen cells, 30 ×  100 B6 
male spleen cells, or a mixture of 30 ×  100 B6.TIa" male spleen cells and 30 ×  10  B6 female spleen cells. 
Effector cells were restimulated in vitro and tested for cytotoxic activity on 51Cr-labeled Con A lymphoblast 
A.TIa  b female target cells. Effector cells were also tested against A/J female targets.  Net 51Cr release did 
not exceed 15.3% at 100:1 effector/target  ratio. 
TAI~LE  II 
Requirement for H-Y and Qa-1 To be Present on the Same Cell for Successful 
Priming via the Footpad 
Stimulator cells 
Rcsponder cells  Target cells  Lytic* 
units  In Vivo  In Vitro 
B6.TIa  a 9  B6 ~  B6 ~  A.TIa  b ~  100 
B6.TIa" d + B6 9  5 
B6.TIa  a female mice were immunized via the footpad with 30 ×  108 B6 male 
spleen cells or a mixture of 30 ×  106 B6.TIa" male and 30 ×  l0  s B6 female 
spleen cells. Effector cells were restimulated in vitro and tested for cytotoxic 
activity on 51Cr-labeled Con A lymphoblast A.TIa  b female target cells. 
* Lytic units =  (Number input responder cells/culture ×  100 required for 25% 
net release)  -1 X  103. 
lation. Thus,  only when  B6.TIa  a  female  mice are  immunized  with  B6  male spleen 
ceils  (H-Y  and  Qa-I  presented  on  the  same  cell)  is  an  anti-Qa-1  b  CTL  response 
elicited. In this manner, H-Y is analogous to a  carrier determinant  requiring linked 
recognition, rather than acting as an adjuvant. 
,Due to the limited size of murine footpads and the restricted lymphatic drainage of 
the footpad  as compared  to the peritoneal cavity, the requirement for linked recog- 
nition might  be circumvented if mice were  immunized  via the  footpad.  Therefore, 
B6:TIa  a female mice were immunized via the footpad  with either 30 ×  106 B6 male 
cells or a  mixture of 30 ×  l0  s B6.TIa  a male cells and 30 ×  106 B6 female cells (Table 
II).. Similar to previous results (see Table I), significant anti-Qa-1  cytotoxic activity 
was generated after in vivo priming with B6 male cells (Table II). However, when the 
H-Y and Qa-1  antigens were presented on separate cells, an anti-Qa-1  response was 
observed in only two out of four experiments. In one of the two positive experiments, 
presented  in  Table  II,  the  number  of  lytic  units  generated  was  only  5%  of  that 
obtained when both  antigens were  presented  on the same cell.  Similar results were 
noted in the  other  experiment.  Therefore,  regardless of the  route of immunization, 
both antigens must be presented on the same cell for successful sensitization. 
The Carrier Determinant Is only Required  for In  Vivo Priming.  Because the CTL response 
can only be elicited after both in vivo priming and in vitro challenge, the requirement 
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was  analyzed.  The  data  in  Table  III  demonstrate  that  B6.Tla  a  female  mice  only 
respond  to  Qa-1 b if primed  in  vivo with  B6  male cells, as expected  (line  1  vs.  3). 
Further, when the helper (H-Y) antigen is present in vitro but not in vivo no cytotoxic 
activity is generated (line 2). However, if B6.TIa  a female mice are primed in vivo with 
B6 male cells, they can then be successfully restimulated in vitro with Qa-1 disparate 
cells possessing  H-Y  determinants  (line  4)  or  lacking  H-Y  determinants  (line  3). 
Therefore,  the extra determinant(s)  is only required for in  vivo priming and  is not 
needed for in vitro restimulation. 
Even though  the carrier determinant  is not required during the in vitro phase of 
the  response,  it  is  possible that  it  could  augment  the  CTL  activity  generated  by 
activating TH in vitro. Therefore, we compared the amount of CTL activity generated 
in  vitro  in  the  presence  or  absence  of the  helper  (H-Y)  determinant.  The  data  in 
Table IV, together with  the data in Table III, show that  an  equivalent amount  of 
CTL  activity is generated following in vitro restimulation with either B6  female or 
male cells. 
Priming  with  the  Helper  Antigen  Only  Does  not  Allow for  the  Generation  of CTL-P In 
Vitro.  The  previous  data  suggest  that  the  addition  of  extra  antigenic  (helper) 
determinants during in vivo priming allows for the generation of CTL-P, which can 
be driven to CTL in vitro. However, it is possible that the helper determinants act by 
increasing the number of Tn cells so that existing unprimed CTL-P can be activated 
in vitro. According to this alternative, CTL.P per se do not require in vivo priming. 
TABLE III 
H-Y (Helper) Determinant Is Required Only during In  Vivo Priming 
Stimulator cells  Net nlCr release 
Line  Responder  Target 
cells  In  In  cells 
Vi vo  Vi t ro  100  50  10 
1  B6,TIa  a ~?  B6 9  B6 9  A.TIa  b 9  0.2  0.0  0.5 
2  B6 d  0.2  0.2  -0.1 
3  B6 d  B6 9  41.5  39.1  18.2 
4  B6 d  45.8  40.0  23.1 
B6.TIa  a female mice were primed in vivo and restimulated in vitro with either 
B6 female spleen cells or B6 male spleen cells. Cytotoxic activity was tested on 
51Cr-labeled Con A lymphoblast A.Tla  b female target cells. 
TABLE IV 
There Is no Carrier Augmentation In Vitro 
Stimulator cells  Net 5~Cr release 
Line  Responder  Target 
eeUs  In  In  cells 
Vivo  Vitro  100  50  10 
1  B6.TIa  a 9  B6 d  B6 ~  A.Tla  b 9  38.4  36.8  23.3 
2  B6 c~  37.9  34.0  28.3 
3  B6 9  BI0.S  54.4  44.2  24.3 
4  B6 ~  39.4  34.4  15.6 
B6.TIa  a female mice were  primed in  vivo with  B6  male  spleen  cells and 
restimulated in vitro with the above panel of spleen cells. Effector cells were 
51  b  tested against  Cr-labeled Con A lymphoblast A.TIa  female or B10.S (Qa-1  b) 
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To investigate these possibilities,  B6.TIa" female mice were primed in vivo with cells 
containing the helper  (H-Y)  determinant  only (B6.TIa  ~ male cells)  and restimulated 
in vitro with either Qa-1 b and H-Y- (B6 female) cells or Qa-1 b and H-Y  + (B6 male) 
cells.  Controls  included  in  vitro  restimulation  with  H-Y  +  (B6.TIa  ~ male)  ceils  and 
testing for anti-H-Y cytolytic activity. 
The  data  presented  in  Table  V  show  that  no  anti-Qa-1  cytolytic  activity  was 
generated when B6.TIa  ~ female mice were primed in vivo with B6.TIa  a male cells and 
rechallenged  with stimulator cells in vitro that  express both helper and Qa-1  deter- 
minants (line 2). As a positive control, we show that B6.Tla" female mice do respond 
when  primed  in  vivo with  cells  expressing  both  H-Y  and  Q a-1  (line  3).  Whereas 
inoculation with B6.Tla  ~ male cells did not prime for anti-Qa-1 CTL, it did prime for 
anti-H-Y CTL (lines 5 and 6). Thus, in vivo priming with only helper determinants 
does  not  allow  for  an  in  vitro  anti-Qa-1  response  although  helper  determinant 
responsive cells were present  in the in vitro culture. 
The Inability of B6. Tla  a Mice to Respond Is Controlled  by an Immune Response Gene.  The 
ability of A/J animals to respond to A.Tla  b, whereas B6.Tla ~ mice do not respond to 
B6, could be due to possible additional antigenic differences at Qa-l-linked  loci that 
exist  between  the  A  strain  congenics  but  are  not  present  between  the  B6  strain 
congenics.  These  additional  alloantigenic  differences could  include  helper  antigens 
similar  to H-Y. Alternatively,  A/J  mice may possess  an Ir gene(s)  that  permits  the 
recognition  of helper  determinants  on  the  Qa-1  molecule  itself.  This  issue  was 
addressed  by immunizing (A/J ×  B6.Tla~)F1 mice with sex-matched B6 spleen cells. 
Because  B6  stimulator  cells  possess  no  additional  antigenic  determinants  that  can 
function  to  stimulate  helper  cell  activity,  these  F1  animals  should  not  be  able  to 
respond  to Qa-I b unless  there  is  an  A  strain  Ir gene.  As  shown  in  Fig.  5,  (A/J  X 
B6.Tla~)F~  animals  do respond to Qa-1 b on sex-matched  B6 stimulator  cells.  Thus, 
the  ability  to respond  to  the  Qa-1 b alloantigen  in  the  absence  of an  added  helper 
determinant  is encoded for by a  dominant gene(s)  in A/J mice. 
To determine  whether  the Ir gene(s)  involved in  the recognition  of helper  deter- 
minants  is  linked  to  the  H-2  complex,  (responder  ×  nonresponder)F1  mice  were 
backcrossed to the nonresponding parent  (B6.Tla  ~) and the progeny were tissue typed 
and  tested  for  anti-Qa-1 b  CTL  activity  (Table  VI).  Of the  18  backcross  animals 
tested,  we found that  10 animals were able to generate ananti-Qa-1 b CTL response 
TABLE V 
Carrier Priming Does Not Allow for a Primary In  Vitro Response 
Stimulator cells  Net 51Cr release 
Line  Responder  cells  Target cells 
In Vivo  In Vitro  100  50  I0 
1  B6.TIa  a 9  B6.TIa  a c~  B6 9  A.TIa  b 9  1  t.8  8.8  4.7 
2  B6 d  11.0  10.3  3.6 
3  B6 6'  B6 9  38.4  36.8  23.3 
4  B6.TIa  ~  6'  B6 9  B6.TIa  a ~  -2.3  -3.4  -2.3 
5  B6 d  37.6  31.7  21.6 
6  B6.TIa" ~3  37.0  33.8  17.9 
B6.Tla  a female mice were primed in vivo with B6.TIa  8 male spleen cells and restimulated in 
vitro with the above panel of spleen ceils. Effector ceils were tested against both 5~Cr-labeled 
Con A lymphoblast A.TIa  b female and B6.TIa  a male target cells. 776  HELPER  DETERMINANTS  FOR  CYTOTOXIC  T  LYMPHOCYTES 
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Flo.  5.  The ability of (A/J x  B6.Tlaa)Fx mice to respond. (A/J X B6.TIa')F1 mice (*) and B6.Tla" 
mice (O) were primed in vivo and restimulated in vitro with sex-matched B6 spleen cells. Cytotoxic 
activity was tested against 5]Cr-labeled Con A lymphoblast A.TIa  b target cells. A/J mice (X) were 
primed in vivo and restimulated in vitro with sex-matched A.Tla  b spleen cells  and were tested 
against B6 target cells. E/T ratios shown are 10:1, 50:1, and 100:1. 
TABLE VI 
Ability of Backcross Animals to Generate an Anti-Qa-1 b Response* 
H-2 haplotype~ 
Anti-Qa- 1  b response:~  Totals 
H-2a/H-2  b  H-2b/H-2  b 
Positive  9  1  10 
Negative  2  6  8 
Totals  11  7 
* (A/J  ×  B6.Tlaa)F1  mice  were  backcrossed  to  the  nonresponding parent 
(B6.Tlaa). These (A/J × B6.Tlaa)F1 X B6.Tla  a mice were primed in vivo and 
restimulated in vitro with sex  matched B6 spleen cells.  Cytotoxic activity 
was tested on 5]Cr-labeled Con A lymphoblast A.Tla  b target cells. 
Positive anti-Qa- 1  b responses represent a net ~lCr release of> 10% at effector/ 
target of 100. 
§ Tissue typing was performed as described in Materials and Methods. 
when  primed  in  vivo  with  sex-matched  B6  cells,  whereas  8  animals  were  not.  To 
determine whether  the A/J  Ir gene is H-2 linked, these same animals were tissue typed 
for  the  responding  H-2  ~  (H-2KkIAkD a)  haplotype  using  an  anti-H-2K k  monoclonal 
antibody.  9  of  11  H-2~/H-2 b  heterozygotes  responded,  while  6  of  7  H-2b/H-2 b 
homozygotes  did  not  respond,  data  consistent  with  the  Ir  gene  being  H-2  linked 
(P  <  0.035).  Because  2  of  11  H-2~/H-2 b  animals  did  not  respond,  an  additional 
non-H-2  linked  Ir  gene  may  also  be  involved.  The  ability  of  one  of  the  seven 
H-2b/H-2 b  homozygotes  to  respond  may  be  explained  by  recombination  between 
H-2K  b (the tissue typing reagent was anti-H-2K k)  and  IA k. J.  KEENE AND J.  FORMAN  777 
Discussion 
The data in this report demonstrate that peripheral CTL-P directed against  the 
alloantigen Qa-1 b require in vivo priming with two kinds of antigenic determinants 
to generate a secondary CTL response in vitro. One of the determinants is found on 
the Qa-1  molecule itself and  is  the target  antigen  for the CTL effector cells.  The 
second determinant need not be on Qa-1, is not recognized by anti-Qa-1  CTL, but 
must be presented together with Qa-1 to prime CTL-P in vivo. We have termed this 
second specificity a  helper determinant since this defines its functional role in the 
generation of CTL effector cells. Although this helper determinant is required in vivo, 
its  presence it not  requisite for the secondary in  vitro boosting of primed CTL-P. 
Further, recognition of the helper determinant is under H-2-1inked Ir gene control. 
Our ability to demonstrate the role of helper determinants in allowing for CTL-P 
priming in vivo was afforded by the observation that B6.Tla  a (Qa-1  a) mice confronted 
with  congenic spleen  cells  from  B6  (Qa-1  b)  donors  failed  to  mount  an  anti-Qa-1 b 
CTL response. The inability of B6.TIa  a animals to respond was not due to a lack of 
CTL-P  against  the  Qa-1 b alloantigen,  because  in  vivo priming  with  noncongenic 
Qa-1  disparate splenocytes from A.BY  mice successfully primed  these animals  for 
subsequent in vitro anti-Qa- 1 CTL activity. In addition to multiple minor-H-antigens, 
defined by the difference in background genes between A  and  B6 animals, we also 
demonstrated  that  the  H-Y  antigen  can  act  as  a  helper  determinant  as  B6.TIa  a 
(Qa-l~ female mice could be successfully primed in vivo with B6 (Qa-1  b) spleen cells 
from male animals. Therefore, extra antigens on the noncongenic cells act as helper 
determinants and allowed us to dissect the rote of both CTL and helper determinants 
that allow for an anti-Qa-1 CTL response. 
There are several reports indicating that the addition of extra antigens augments 
both CTL and humoral responses against cell membrane alloantigens. For example, 
Lake and Douglas (26) have shown that anti-Thy-1 humoral responses are augmented 
when the donor-recipient pairs are noncongenic for the Thy-1 gene. Wernet and Lilly 
(27) found that anti-H-2D  b alloantisera of the IgG class could not be raised by cross 
immunizing mice congenic at the D-end of the H-2 complex, whereas this sera could 
be produced using noncongenic recipients. Butler and Battisto (18) showed that the 
primary in vivo anti-TNP CTL response of popliteal lymph node cells following a 
footpad inoculation of TNP-derivatized cells could only occur if the TNP cells came 
from Mls disparate animals. 
The role of a  helper antigen could be thought of in two ways;  (a) as an adjuvant 
that nonspecifically augments an immune response, or (b) as a carrier determinant as 
defined in the linked-recognition interpretation of T-B collaboration (28). We have 
addressed  this  issue  by  priming  animals  with  the  CTL  and  helper  determinants 
presented on separate antigen-presenting cells. Our data clearly show that both the 
CTL (Qa-1 b) and the helper (H-Y) determinants need be on the same cell for in vivo 
priming, thus supporting the proposition that linked recognition involving an inter- 
action between cells recognizing CTL and helper determinants is required. This was 
not only observed using the intraperitoneal route of inoculation, but also when cells 
were injected into the same footpad, and differs from the results of Butler and Battisto 
(18) who found that TNP and Mls determinants could be presented on different cells. 
Zinkernagel  et  al.  (15)  and  von  Boehmer and  Haas  (16),  using  bone  marrow- 
reconstituted radiation  chimeras,  showed  a  necessity for I  region  sharing  between 778  HELPER DETERMINANTS FOR CYTOTOXtC T  LYMPHOCYTES 
donor lymphocytes and host radio-resistant thymus cells to generate antigen-specific 
cytotoxic T  cell activity. However, even if it is assumed  that  the requirement for I 
region compatibility reflects the ability to sensitize helper cells, this approach does 
not  allow for a  determination of when helper cell activity is required. More direct 
evidence has come from the experiments of Altman et al.  (17)  and  Hamaoka et al. 
(29)  who  showed  that  primed  anti-TNP  Tn  augment  the  in  vitro CTL response 
against a syngeneic tumor. However, in these experiments anti-tumor responses could 
be induced without the addition of the TNP (helper) determinant. Further, animals 
confronted with TNP-tumor cells had to be pretreated with dinitrophenol-GL before 
priming for helper cell activity, otherwise suppression rather than augmentation of 
the CTL response occurred. Therefore, it is not clear whether the anti-TNP helper 
cells were required for generating CTL-P in vitro or for overcoming the activity of 
TNP-specific suppressor cells. Green et al. (30) have shown that in vitro CTL activity 
against  E~G2 cells,  a  B6 leukemia bearing AKR/Gross  virus antigens,  requires in 
vivo priming  with  AKR  leukemia  cells  to  generate  in  vitro  CTL-P  that  can  be 
sensitized against  E~G2 cells.  Although a variable expression of tumor antigens or a 
difference in immunogenicity of these leukemia lines may in part  account for their 
results, it is likely that the H-2  k alloantigens serve as helper determinants, similar to 
H-Y in the anti-Qa-1 response. 
Recognition of the helper determinant in vivo may be required either to generate 
in vitro CTL-P, or alternatively, prime Tn, which subsequently activate unprimed 
CTL-P in vitro. We used two approaches to distinguish  between these possibilities. 
First, we showed that animals primed in vivo only with the H-Y antigen could not 
generate  anti-Qa-1  CTL  activity  when  challenged  in  vitro  with  stimulator  cells 
containing both  Qa-1  and  H-Y.  Second,  omission  of the  helper  antigen  by using 
female stimulator cells in  vitro still  allowed  for the generation of anti-Qa-1 b CTL 
activity. Taken  together, our data  demonstrate  that  helper  determinants  must  be 
presented during in vivo priming together with CTL determinans in order to prime 
peripheral CTL-P. 
Whereas we were able to show that  helper determinants  are requisite during in 
vivo priming of anti-Qa-1  CTL-P, no such  requirement could be demonstrated  in 
vitro. Accordingly, cultures of B6.TIa  a female splenocytes taken from animals primed 
with B6 male cells generated as much cytolytic activity when challenged in vitro with 
B6  female  as  B6  male  stimulator  cells.  While  this  demonstrates  that  the  helper 
determinant is not required for the in vitro phase of the CTL response, it does not 
rule  out  a  possible  contribution  of  putative  helper  activity,  because  anti-Qa-1 b 
CTL-P in vitro must undergo cell division (unpublished results). Thus, it is possible 
that only a small amount of helper activity is required for the in vitro CTL response 
and can be provided by recognition of the Qa-1 b antigen, itself, whereas during in 
vivo priming more helper activity is required and can only be provided by recognition 
of the additional  (H-Y) helper determinant. 
Other laboratories have been unable to demonstrate an obligatory role for Tn, as 
defined by the addition of IL-2, in the generation of peripheral CTL in vitro. Thus, 
with the exception of thymocytes (9, 10), peripheral CTL-P can be sensitized without 
the addition of exogenous IL-2. The ability to sensitize CTL-P without the addition 
of IL-2 could either reflect the presence of IL-2-secreting TH in peripheral lymphoid 
organs or the fact that CTL-P do not require this helper (IL-2) signal.  If the latter J. KEENE AND J. FORMAN  779 
case is correct, then we suggest that the helper signal has been previously supplied in 
vivo. This implies that all CTL responses measured in vitro are derived from primed 
CTL-P, and is consistent with the data of Finberg et al.  (31), who have postulated 
that  anti-H-2  CTL-P are  derived from cells  previously exposed  to environmental 
antigens. 
Several investigators  (12-14)  have  suboptimized  in  vitro  culture  conditions  by 
treating stimulator cells with physical agents such as ultraviolet light, heat, sonication, 
etc., to show that peripheral CTL-P require the addition of helper signals or IL-2 to 
generate CTL-effector activity. However, these treatments may not reflect the ability 
of CTL-P to become activated when confronted with antigen on untreated stimulator 
cells. Finberg et al. (11) and Fujiwara and Shearer (32) have demonstrated that helper 
activity can augment anti-TNP CTL responses in vitro. Interestingly, Finberg et al. 
(11) have also shown that anti-TNP suppressor cells can inhibit the augmentation of 
anti-TNP CTL activity observed in the presence of TH, but cannot inhibit the residual 
CTL activity seen in  the absence of exogenous TH. Those data,  together with  the 
evidence provided in this report, suggests that TH activity may not be required for the 
in  vitro generation of CTL from CTL-P. If CTL are generated in  the absence of 
IL-2, we suggest that there is a  relatively high frequency of antigen-specific CTL-P, 
and that at least a few rounds of cell division can occur in the absence of IL-2, which 
would be sufficient to produce detectable CTL activity. 
Ashman  and Mullbacher  (33)  have shown that  primed helper cells added  to in 
vitro  cultures  of unprimed  spleen  cells  can  allow  for  a  primary  anti-viral  CTL 
response. Thus,  under some circumstances helper activity can be demonstrated  as 
necessary in vitro. Since it would be expected that unprimed mice would have only 
a small frequency of specific anti-viral CTL-P,several rounds of cell division may be 
required to amplify clones to produce detectable effector activity, thus making the 
response more IL-2 dependent. 
The ability to recognize the helper determinant on the Qa-I antigen is under H-2- 
linked  Ir-gene control. This was  demonstrated by the  finding that  all  (B6.TIa  a  × 
A/J)FI mice generated anti-Qa-1 CTL when confronted with Qa-1 b on B6 splenocytes 
and that 9 of 10 responding backcross animals were H-2~/H-~ heterozygotes. There- 
fore, these results are in agreement with other data investigating the role of Ir genes 
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FIG. 6.  A model for minimal cellular interactions  required in the generation of CTL. Unprimed 
CTL-P in vivo  require a differentiation  signal from one helper cell (Tin) and a proliferation  (IL-2) 
signal from a second helper cell (T~) in the presence of antigen to generate CTL effector and 
memory (primed CTL-P) cells. In vitro restimulation (---) of primed CTL-P requires only a 
proliferation  signal in the presence  of antigen. 780  ItELPER  DETERMINANTS  FOR  CYTOTOXIC T  LYMPHOCYTES 
in  CTL  recognition  of antigen  (16).  Since 2  of  11  H-2a/H-2  b  heterozygotes were 
nonresponders to Qa-1, it is also possible that a second non-H-2-1inked Ir gene may be 
involved. 
While the data in this report can be interpreted as indicating that helper determi- 
nants activate IL-2 secreting Th in vivo to allow for sensitization of CTL-P, we would 
like to propose an alternative hypothesis diagramed in Fig. 6. This hypothesis is based 
partly on the findings that the expansion and differentiation of B cell precursors into 
antibody-secreting cells requires at least  two different T  cell activities  (34-36), and 
the proposition that  IL-2 is requisite during in vitro culture to generate CTL from 
CTL-P. Accordingly, we propose that the H-Y helper determinant activates a helper 
cell (Tin) that provides a  differentiation signal to CTL-P that  must  be delivered in 
the presence of antigen (Qa-I). Following or together with that interaction, a second 
signal,  IL-2, elaborated by a  different helper cell  (Tin), allows  for proliferation of 
CTL-P into both CTL effector and memory cells, the latter being indistinguishable 
from primed CTL-P. During in  vitro culture, primed CTL-P only require an IL-2 
signal from one of these helper cells, TH2, to generate effector cells.  According to our 
hypothesis, it follows that the defect in B6.Tla  a animals is not a lack of IL-2 secreting 
Tn2, but  rather  in  Tnl  that  provide a  differentiation signal.  Therefore, a  testable 
prediction of the model is that B6.TIa" animals have anti-Qa-1 TH2. Experiments are 
currently in progress to test this possibility. 
Summary 
B6.TIa" (Qa-l")  mice that are primed in vivo and restimulated in vitro with Qa-1 
congenic  spleen  cells  from  B6  (Qa-I b)  animals  are  unable  to  generate  anti-Qa-I b 
cytotoxic T  lymphocytes (CTL). This nonresponsive pattern was observed regardless 
of the route of immunization or the time of testing in vitro. 
Although  B6.TIa  a mice are  nonresponders to Qa-I b when  presented on B6 cells, 
these mice can generate anti-Qa-1 b CTL when primed in vivo with Qa-1  and  H-Y 
aUoantigens (females primed with B6 male cells) or Qa-1  and minor-H- alloantigens 
(primed with sex-matched A.BY cells). Therefore, the inability to generate anti-Qa-1 b 
CTL is due to a  lack of helper or accessory antigens on B6 immunizing cells obliga- 
tory during in vivo priming, rather than  an absence of anti-Qa-1 b CTL precursors 
(CTL-P).  Demonstration that  the additional  determinants  required during in  vivo 
priming  actually  function  as  carrier  or  helper  determinants  was  shown  by  the 
requirement  for linked  recognition of Qa-1  and  the  helper determinants  (H-Y)  in 
vivo, and  the  fact  that  H-Y  was  not  present  on  susceptible  target  ceils.  Animals 
primed  in  vivo with  H-Y  only could  not  generate  anti-Qa-1  CTL  activity  when 
challenged in vitro with both Qa-1 and H-Y, indicating that recognition of the helper 
determinant causes in vivo priming of CTL-P rather than generating helper activity 
that might activate unprimed CTL-P in vitro. 
Whereas  unprimed  peripheral  CTL-P require the  presence of both Qa-I  (CTL) 
and  H-Y  (helper)  determinants for successful in  vivo priming, helper determinants 
were not required in vitro because primed CTL-P from B6.TIa  a mice could be driven 
to CTL in vitro using sex-matched B6 stimulator cells. 
The  generation  of anti-Qa-1 b CTL  is  under  immune  response  (Ir) gene control 
because  F1  mice, obtained  by  crossing  responder  A/J  with  nonresponder  B6.TIa  a 
animals, generated CTL to the Qa-I b alloantigen when presented on B6 spleen cells. j.  KEENE  AND J.  FORMAN  781 
Progeny testing of backcross mice further demonstrated that the lr gene(s) is linked to 
the H-2 complex. 
These data  indicate  that  an H-2-1inked [r gene controls the recognition of helper 
determinants  required  for CTL priming in  vivo. These helper determinants  can be 
distinguished  from  CTL  determinants  and  both  must  be  recognized  together  for 
successful priming of CTL-P. 
We wish to thank Bettye Jo Washington for her typing of this manuscript. 
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